Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Ophthalmology Contract Research Organization (CRO) Market
Ophthalmology Contract Research Organization (CRO) Market accounted for USD 2.2 billion in 2022 and is anticipated to grow with a CAGR of 7.3% over the forecast period, to reach an estimated value of USD 4.4 billion by 2032.
Increasing prevalence of eye diseases coupled with rising demand for ophthalmic treatment are the major factors driving the industry by 2032. Outsourcing enables companies to access specialized expertise, advanced technologies, and state-of-the-art facilities, reducing the time and costs associated with in-house development of ophthalmic drug, devices, and diagnostic solutions in vision care. Furthermore, increasing number of clinical trials being conducted worldwide and growing emphasis of pharma companies on R&D activities for development of novel products.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Ophthalmology Contract Research Organization (CRO) Market Size in 2022: | USD 2.2 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 7.3% |
2032 Value Projection: | USD 4.4 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 281 |
Tables, Charts & Figures: | 413 |
Segments covered: | Service Type, Therapy, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Ophthalmology contract research organizations are specialized service providers that offer comprehensive research and development support specifically focused on ophthalmology drugs, ophthalmic medical devices, and therapies. These services are outsourced by pharmaceutical, biopharmaceutical, and medical device company among others.